66 results
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
existing cash to achieve our business goals, business strategy, market size for our product candidates, potential future milestone and royalty payments
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
and targets contained herein are based on Ipsen’s management strategy, current views and assumptions. Such statements involve known and unknown risks
8-K
EX-99.1
slk2wn ho9
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
5icvw gah
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
n1dpmqta
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
PRE 14A
3p99h93e
14 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
br6tcch8 vyh42
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm